Download PDF
Semin Respir Crit Care Med 2014; 35(06): 715-722
DOI: 10.1055/s-0034-1395503
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Management of Parapneumonic Effusions and Empyema

Ioannis Psallidas
1   University of Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom
2   Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
,
John P. Corcoran
1   University of Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom
2   Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
,
Najib M. Rahman
1   University of Oxford Respiratory Trials Unit, Churchill Hospital, Oxford, United Kingdom
2   Oxford Centre for Respiratory Medicine, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
3   NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
02 December 2014 (online)

    Permissions and Reprints

Abstract

Pleural infection remains a common and serious respiratory condition with important implications for patients and health-care services. This review will cover the management of pleural infection including medical treatment, the role of intrapleural agents and surgical treatment. We discuss the directions that future research in this important area might take. Increasing incidence of pleural infection has been reported worldwide without a clear explanation. The pathogens responsible for pleural infection differ from those in pneumonia. Proper antibiotic selection and pleural fluid drainage remain the cornerstones of treatment. There is no evidence in adult pleural infection to support the routine use of intrapleural fibrinolytics to alter clinically meaningful outcomes; however, combined intrapleural tissue plasminogen activator (tPA) and deoxyribonuclease (DNase) therapy may have a future role. The role of medical thoracoscopy remains unproven. Surgical referral should be considered in patients who fail to respond to standard medical management after 5 to 7 days. Despite advances in microbiology, medical management, and surgery, the mortality of pleural infection at one year remains approximately 20% for the last two decades. Future studies are required to validate predictive scores for patients' stratification (RAPID score) and the role of fibrinolytics (combination of tPA plus DNase). Surgical drainage remains a vital treatment option, but ongoing research is required to define the group of patients who would benefit most and when, in the disease course, this treatment should be offered.

Keywords

pleural infection - empyema - parapneumonic effusion - fibrinolytics - tPA
 

  • References

  • 1 Grijalva CG, Zhu Y, Nuorti JP, Griffin MR. Emergence of parapneumonic empyema in the USA. Thorax 2011; 66 (8) 663-668
    CrossrefPubMedGoogle Scholar
  • 2 Sonnappa S, Cohen G, Owens CM , et al. Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyema. Am J Respir Crit Care Med 2006; 174 (2) 221-227
    CrossrefPubMedGoogle Scholar
  • 3 Ferguson AD, Prescott RJ, Selkon JB, Watson D, Swinburn CR. The clinical course and management of thoracic empyema. QJM 1996; 89 (4) 285-289
    CrossrefPubMedGoogle Scholar
  • 4 Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160 (5 Pt 1) 1682-1687
    CrossrefPubMedGoogle Scholar
  • 5 Maskell NA, Davies CW, Nunn AJ , et al; First Multicenter Intrapleural Sepsis Trial (MIST1) Group. U.K. Controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352 (9) 865-874
    CrossrefPubMedGoogle Scholar
  • 6 Rahman NM, Maskell NA, West A , et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infection. N Engl J Med 2011; 365 (6) 518-526
    CrossrefPubMedGoogle Scholar
  • 7 Nielsen J, Meyer CN, Rosenlund S. Outcome and clinical characteristics in pleural empyema: a retrospective study. Scand J Infect Dis 2011; 43 (6-7) 430-435
    CrossrefPubMedGoogle Scholar
  • 8 Corcoran JP, Hallifax R, Rahman NM. New therapeutic approaches to pleural infection. Curr Opin Infect Dis 2013; 26 (2) 196-202
    CrossrefPubMedGoogle Scholar
  • 9 Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46 (2) 174-182
    CrossrefPubMedGoogle Scholar
  • 10 Burgos J, Lujan M, Falcó V , et al. The spectrum of pneumococcal empyema in adults in the early 21st century. Clin Infect Dis 2011; 53 (3) 254-261
    CrossrefPubMedGoogle Scholar
  • 11 Muñoz-Almagro C, Selva L, Pallares R. Influence of pneumococcal vaccine on the incidence of empyema. Curr Opin Pulm Med 2010; 16 (4) 394-398
    CrossrefPubMedGoogle Scholar
  • 12 Burgos J, Falcó V, Pahissa A. The increasing incidence of empyema. Curr Opin Pulm Med 2013; 19 (4) 350-356
    CrossrefPubMedGoogle Scholar
  • 13 Strange C, Sahn SA. The definitions and epidemiology of pleural space infection. Semin Respir Infect 1999; 14 (1) 3-8
    PubMedGoogle Scholar
  • 14 Chen KY, Hsueh PR, Liaw YS, Yang PC, Luh KT. A 10-year experience with bacteriology of acute thoracic empyema: emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000; 117 (6) 1685-1689
    CrossrefPubMedGoogle Scholar
  • 15 Meyer CN, Rosenlund S, Nielsen J, Friis-Møller A. Bacteriological aetiology and antimicrobial treatment of pleural empyema. Scand J Infect Dis 2011; 43 (3) 165-169
    CrossrefPubMedGoogle Scholar
  • 16 Farjah F, Symons RG, Krishnadasan B, Wood DE, Flum DR. Management of pleural space infections: a population-based analysis. J Thorac Cardiovasc Surg 2007; 133 (2) 346-351
    CrossrefPubMedGoogle Scholar
  • 17 Maskell NA, Batt S, Hedley EL, Davies CW, Gillespie SH, Davies RJ. The bacteriology of pleural infection by genetic and standard methods and its mortality significance. Am J Respir Crit Care Med 2006; 174 (7) 817-823
    CrossrefPubMedGoogle Scholar
  • 18 Sahn SA, Taryle DA, Good Jr JT. Experimental empyema. Time course and pathogenesis of pleural fluid acidosis and low pleural fluid glucose. Am Rev Respir Dis 1979; 120 (2) 355-361
    PubMedGoogle Scholar
  • 19 Alemán C, Alegre J, Monasterio J , et al. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions. Clin Sci (Lond) 2003; 105 (5) 601-607
    CrossrefPubMedGoogle Scholar
  • 20 Kroegel C, Antony VB. Immunobiology of pleural inflammation: potential implications for pathogenesis, diagnosis and therapy. Eur Respir J 1997; 10 (10) 2411-2418
    CrossrefPubMedGoogle Scholar
  • 21 Davies HE, Davies RJ, Davies CW ; BTS Pleural Disease Guideline Group. Management of pleural infection in adults: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii41-ii53
    CrossrefPubMedGoogle Scholar
  • 22 Sahn SA, Light RW. The sun should never set on a parapneumonic effusion. Chest 1989; 95 (5) 945-947
    CrossrefPubMedGoogle Scholar
  • 23 Balfour-Lynn IM, Abrahamson E, Cohen G , et al; Paediatric Pleural Diseases Subcommittee of the BTS Standards of Care Committee. BTS guidelines for the management of pleural infection in children. Thorax 2005; 60 (Suppl. 01) i1-i21
    CrossrefPubMedGoogle Scholar
  • 24 Whiley RA, Beighton D, Winstanley TG, Fraser HY, Hardie JM. Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus (the Streptococcus milleri group): association with different body sites and clinical infections. J Clin Microbiol 1992; 30 (1) 243-244
    PubMedGoogle Scholar
  • 25 Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics 2010; 125 (1) 26-33
    CrossrefPubMedGoogle Scholar
  • 26 Langley JM, Kellner JD, Solomon N , et al. Empyema associated with community-acquired pneumonia: a Pediatric Investigator's Collaborative Network on Infections in Canada (PICNIC) study. BMC Infect Dis 2008; 8: 129
    CrossrefPubMedGoogle Scholar
  • 27 Menzies SM, Rahman NM, Wrightson JM , et al. Blood culture bottle culture of pleural fluid in pleural infection. Thorax 2011; 66 (8) 658-662
    CrossrefPubMedGoogle Scholar
  • 28 Insa R, Marín M, Martín A , et al. Systematic use of universal 16S rRNA gene polymerase chain reaction (PCR) and sequencing for processing pleural effusions improves conventional culture techniques. Medicine (Baltimore) 2012; 91 (2) 103-110
    CrossrefPubMedGoogle Scholar
  • 29 Blaschke AJ, Heyrend C, Byington CL , et al. Molecular analysis improves pathogen identification and epidemiologic study of pediatric parapneumonic empyema. Pediatr Infect Dis J 2011; 30 (4) 289-294
    CrossrefPubMedGoogle Scholar
  • 30 Runyon BA, Antillon MR, Akriviadis EA, McHutchison JG. Bedside inoculation of blood culture bottles with ascitic fluid is superior to delayed inoculation in the detection of spontaneous bacterial peritonitis. J Clin Microbiol 1990; 28 (12) 2811-2812
    PubMedGoogle Scholar
  • 31 Ferrer A, Osset J, Alegre J , et al. Prospective clinical and microbiological study of pleural effusions. Eur J Clin Microbiol Infect Dis 1999; 18 (4) 237-241
    CrossrefPubMedGoogle Scholar
  • 32 Taryle DA, Good Jr JT, Morgan III EJ, Reller LB, Sahn SA. Antibiotic concentrations in human parapneumonic effusions. J Antimicrob Chemother 1981; 7 (2) 171-177
    CrossrefPubMedGoogle Scholar
  • 33 Fine NL, Smith LR, Sheedy PF. Frequency of pleural effusions in mycoplasma and viral pneumonias. N Engl J Med 1970; 283 (15) 790-793
    CrossrefPubMedGoogle Scholar
  • 34 Randolph KA, Beekman JF. Legionnaires' disease presenting with empyema. Chest 1979; 75 (3) 404-406
    CrossrefPubMedGoogle Scholar
  • 35 Ko SC, Chen KY, Hsueh PR, Luh KT, Yang PC. Fungal empyema thoracis: an emerging clinical entity. Chest 2000; 117 (6) 1672-1678
    CrossrefPubMedGoogle Scholar
  • 36 Wahidi MM, Willner DA, Snyder LD, Hardison JL, Chia JY, Palmer SM. Diagnosis and outcome of early pleural space infection following lung transplantation. Chest 2009; 135 (2) 484-491
    CrossrefPubMedGoogle Scholar
  • 37 Maclayton DO, Hall II RG. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus. Ann Pharmacother 2007; 41 (2) 235-244
    CrossrefPubMedGoogle Scholar
  • 38 Naimi TS, LeDell KH, Como-Sabetti K , et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290 (22) 2976-2984
    CrossrefPubMedGoogle Scholar
  • 39 Rahman NM, Maskell NA, Davies CW , et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010; 137 (3) 536-543
    CrossrefPubMedGoogle Scholar
  • 40 Bouros D, Schiza S, Tzanakis N, Chalkiadakis G, Drositis J, Siafakas N. Intrapleural urokinase versus normal saline in the treatment of complicated parapneumonic effusions and empyema. A randomized, double-blind study. Am J Respir Crit Care Med 1999; 159 (1) 37-42
    CrossrefPubMedGoogle Scholar
  • 41 Diacon AH, Theron J, Schuurmans MM, Van de Wal BW, Bolliger CT. Intrapleural streptokinase for empyema and complicated parapneumonic effusions. Am J Respir Crit Care Med 2004; 170 (1) 49-53
    CrossrefPubMedGoogle Scholar
  • 42 Thomson AH, Hull J, Kumar MR, Wallis C, Balfour Lynn IM. Randomised trial of intrapleural urokinase in the treatment of childhood empyema. Thorax 2002; 57 (4) 343-347
    CrossrefPubMedGoogle Scholar
  • 43 Henke CA, Leatherman JW. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. Am Rev Respir Dis 1992; 145 (3) 680-684
    CrossrefPubMedGoogle Scholar
  • 44 Taylor RF, Rubens MB, Pearson MC, Barnes NC. Intrapleural streptokinase in the management of empyema. Thorax 1994; 49 (9) 856-859
    CrossrefPubMedGoogle Scholar
  • 45 Wait MA, Sharma S, Hohn J, Dal Nogare A. A randomized trial of empyema therapy. Chest 1997; 111 (6) 1548-1551
    CrossrefPubMedGoogle Scholar
  • 46 Bilgin M, Akcali Y, Oguzkaya F. Benefits of early aggressive management of empyema thoracis. ANZ J Surg 2006; 76 (3) 120-122
    CrossrefPubMedGoogle Scholar
  • 47 Misthos P, Sepsas E, Konstantinou M, Athanassiadi K, Skottis I, Lioulias A. Early use of intrapleural fibrinolytics in the management of postpneumonic empyema. A prospective study. Eur J Cardiothorac Surg 2005; 28 (4) 599-603
    CrossrefPubMedGoogle Scholar
  • 48 Talib SH, Verma GR, Arshad M, Tayade BO, Rafeeque A. Utility of intrapleural streptokinase in management of chronic empyemas. J Assoc Physicians India 2003; 51: 464-468
    PubMedGoogle Scholar
  • 49 Singh M, Mathew JL, Chandra S, Katariya S, Kumar L. Randomized controlled trial of intrapleural streptokinase in empyema thoracis in children. Acta Paediatr 2004; 93 (11) 1443-1445
    CrossrefPubMedGoogle Scholar
  • 50 Aye RW, Froese DP, Hill LD. Use of purified streptokinase in empyema and hemothorax. Am J Surg 1991; 161 (5) 560-562
    CrossrefPubMedGoogle Scholar
  • 51 Thommi G, Shehan JC, Robison KL, Christensen M, Backemeyer LA, McLeay MT. A double blind randomized cross over trial comparing rate of decortication and efficacy of intrapleural instillation of alteplase vs placebo in patients with empyemas and complicated parapneumonic effusions. Respir Med 2012; 106 (5) 716-723
    CrossrefPubMedGoogle Scholar
  • 52 Jaffé A, Bush A. Cystic fibrosis: review of the decade. Monaldi Arch Chest Dis 2001; 56 (3) 240-247
    PubMedGoogle Scholar
  • 53 Simpson G, Roomes D, Heron M. Effects of streptokinase and deoxyribonuclease on viscosity of human surgical and empyema pus. Chest 2000; 117 (6) 1728-1733
    CrossrefPubMedGoogle Scholar
  • 54 Janda S, Swiston J. Intrapleural fibrinolytic therapy for treatment of adult parapneumonic effusions and empyemas: a systematic review and meta-analysis. Chest 2012; 142 (2) 401-411
    CrossrefPubMedGoogle Scholar
  • 55 Rahman NM, Ali NJ, Brown G , et al; British Thoracic Society Pleural Disease Guideline Group. Local anaesthetic thoracoscopy: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65 (Suppl. 02) ii54-ii60
    PubMedGoogle Scholar
  • 56 Brutsche MH, Tassi GF, Györik S , et al. Treatment of sonographically stratified multiloculated thoracic empyema by medical thoracoscopy. Chest 2005; 128 (5) 3303-3309
    CrossrefPubMedGoogle Scholar
  • 57 Ravaglia C, Gurioli C, Tomassetti S , et al. Is medical thoracoscopy efficient in the management of multiloculated and organized thoracic empyema?. Respiration 2012; 84 (3) 219-224
    CrossrefPubMedGoogle Scholar
  • 58 LeMense GP, Strange C, Sahn SA. Empyema thoracis. Therapeutic management and outcome. Chest 1995; 107 (6) 1532-1537
    CrossrefPubMedGoogle Scholar
  • 59 Shin JA, Chang YS, Kim TH , et al. Surgical decortication as the first-line treatment for pleural empyema. J Thorac Cardiovasc Surg 2013; 145 (4) 933-939
    CrossrefPubMedGoogle Scholar
  • 60 Chambers A, Routledge T, Dunning J, Scarci M. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema?. Interact Cardiovasc Thorac Surg 2010; 11 (2) 171-177
    CrossrefPubMedGoogle Scholar
  • 61 Kho P, Karunanantham J, Leung M, Lim E. Debridement alone without decortication can achieve lung re-expansion in patients with empyema: an observational study. Interact Cardiovasc Thorac Surg 2011; 12 (5) 724-727
    CrossrefPubMedGoogle Scholar
  • 62 Kurt BA, Winterhalter KM, Connors RH, Betz BW, Winters JW. Therapy of parapneumonic effusions in children: video-assisted thoracoscopic surgery versus conventional thoracostomy drainage. Pediatrics 2006; 118 (3) e547-e553
    CrossrefPubMedGoogle Scholar
  • 63 St Peter SD, Tsao K, Spilde TL , et al. Thoracoscopic decortication vs tube thoracostomy with fibrinolysis for empyema in children: a prospective, randomized trial. J Pediatr Surg 2009; 44 (1) 106-111 , discussion 111
    CrossrefPubMedGoogle Scholar
  • 64 Rahman NM, Kahan BC, Miller RF, Gleeson FV, Nunn AJ, Maskell NA. A clinical score (RAPID) to identify those at risk for poor outcome at presentation in patients with pleural infection. Chest 2014; 145 (4) 848-855
    CrossrefPubMedGoogle Scholar